Pharmacological actions and clinical efficacy of agomelatine

Wen-Ji DAI,Tian-Mei SI
DOI: https://doi.org/10.3969/j.issn.1000-6729.2012.03.007
2012-01-01
Abstract:Major depression is one of the high prevalent and leading disable mental disorders,and the available drugs are mainly focusing on the monoamine systems.Agomelatine is a novel antidepressant,possessing both melatonergic agonist and 5-hydroxytryptamine 2C(5-HT_2C) antagonist properties.Several lines of evidence from the animal model and clinical studies have showed that agemelatine has definite antidepressant efficacy and has some superiorities such as quick onset time,good tolerance.Agomelatine has been a new choice for treatment of depression.This review summarized the pharmacological action of agemelatine,aimed to help the clinical practictioner understanding this drug more clearly and use it reasonably.
What problem does this paper attempt to address?